GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Atricure, Inc. (ATRC) [hlAlert]

Rating:
Mkt Outperform
ATRC
up 113.57 %

Atricure, Inc. (ATRC) rated Mkt Outperform with price target $15 by Rodman & Renshaw

Posted on: Thursday,  Feb 28, 2008  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Atricure, Inc. (NASDAQ: ATRC) on 02/28/2008, when the stock price was $12.30.
Since then, Atricure, Inc. has gained 113.58% as of 01/06/2016's recent price of $26.27.
If you would have followed this Rodman & Renshaw's recommendation on ATRC, you would have gained 113.57% of your investment in 2869 days.

AtriCure, Inc. is a medical device company that develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. The Company's primary product line, which accounts for a majority of its revenues, is the AtriCure Isolator system. AtriCure's Isolator system consists primarily of a compact power generator known as an ablation and sensing unit (ASU), a switchbox unit (ASB), which allows physicians to toggle between multiple products and multiple configurations of its Isolator clamps, including its Isolator Synergy clamps. AtriCure also sells a multifunctional bipolar pen, or multifunctional pen, which is often used by physicians in combination with its Isolator system to ablate cardiac tissue and for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias. In 2008, The Company received FDA approval for its EXCLUDE clinical trial.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2008 8:25 AM Buy
None
12.30 15.00
as of 12/24/2008
1 Week down  -22.46 %
1 Month down  -16.40 %
3 Months down  -41.20 %
1 YTD down  -51.80 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy